scott gottlieb truthful andt misleading. , the dr. scott gottlieb columnmmissioner of the in "the washington post" about cbd. phone lines for cbd users, 202-748-8003. otherwise, phone lines as usual. davia is up first out of huntsville. uses cbd. go ahead. caller: good morning, dr. gottlieb. i wanted to challenge you because it sounds like you are really only talking about cbd in the food supply. i'm actually recovering from my the head of the pain department at university of alabama birmingham highly recommends cbd as an alternative to opiates for pain treatment. , really, whatus are your thoughts on that? beinge talk about cbd hemp derived or cannabis derived, there are a lot of things and play with that as well as just molecular structure . guest: there's other active ingredients in the cannabis plant, certainly, and in cbd. cbd is available as a dietary supplement. dietary supplements are regulated under food regulations. when we talk about something being in the food supply, it is interchangeable with being a dietary supplement a

scott gottlieb here and he started with epidialects. gw pharma.do the power pitch. >> fast pitch. >> and we talked about this stock 18 months ago. look at the quarter they just reported revenue beat in a major way. you wonder how many more indications. people say valuation is crazy. they said that $100 ago. that's one number two, and i'll say it again. history is riddled with disastered outcomes born of great intentions and that's what we're seeing now and it's manifesting itself in the gold market it goes up every single day. pete najarian has been on this for a while and we've been talking about it at least the last six months. gold is going higher. >> should there be a place for gold in your portfolio these days >> i think gold is a great diversifying asset class stocks and bonds have grown more correlated and gold is more uncorrelated with everything so it's a great place to hedge your risk but i think within the market what is most compelling to me right now and what the world isn't giving credit to is the u.s. financial sector. so financials

scott gottlieb, former head of the food and drug administration on why he thinks the fda needs to take more action on cannabidiol, or cbd. national reliance on mental illness senior policy advisor ronald hornburg talks about red flag laws. and as part of our podcast week, we talk with mark leon goldberg host of "the goldburg dispatches podcast." watch c-span -- washington journal 7:00 eastern. is chrisay, our guest star wall, podcast cohost of "perino instar walt, i will tell you what." on friday, jennifer briney host of "congressional dish." in 197ma:

working with cdc and state health officials as quickly as possible to gather more information scott gottlieb was the head of that agency until april. >> we addicted a whole generation of kids on nicotine through these vaping products. this isn't like a teen fad that you can turn off. >> reporter: he calls it an addiction crisis wre going to be at a point where we have to ask whethe some of these products should come off the market >> reporter: tristan who will likely have permanent lung scarring vows to never touch an e-cigarette again. >> when you walk into a high school, walk into the bathroom, you'll see ten or 12 kids huddling around, passing one around if the short term effects are this bad, what good can come out of it? >> reporter: questions now facing health officials and millions of kids headed back to school kristen dahlgren, nbc news >>> just ahead tonight, our nbc news exclusive. inside the tsa's new warning to travelers that starts today about the new i.d. you'll soon need to fly. you'll want to see this story >>> also the mystery in the wild caught on camera what's causing thes

e-cigarettes caused the seizures when this investigation first was launched the fda was under scott gottlieb i got this statement, it was expected that we would elicit more reporting after the initial public advisory. we notified that we identified cases of seizures, particularly in the setting of e-cigarette use among kids 92 additional reports over that short period of time is concerning that from scott gottlieb who was the head of the agency when they launched that investigation in the first place. shares of you wialtria which ow stake in juul a flat, a touch in the red. >> thank you very much, we'll keep our eyes on that one. >>> one technician said we could be in selloff that makes what happened in december look tame oil is down 14% in august, and it's early, and we're not even halfway through the month. just how low can oil go. that's coming up on "power lunch. >>> welcome back to power lunch. i'm mike santoli at the new york stock exchange the dow coming back from the day's lows but still losing nearly a thousand points this month. the markets heavy caterpillar, 3 m, goldman sachs, ap

scott gottlieb sitting here talk to him about the latest news on vaping and health risk. >>> counting interview with james bullard as well a few minutes until we hear from him. don't miss it. "squawk box" will be right back. >> announcer: time now for today's aflac trivia question. what type of car saved french president charles de gaulle from an assassination attempt the answer when cnbc's "squawk box" continu. es but not when to use it. do i use aflac when the kids get slime in the plumbing? no. that's home owner's insurance. slime in my motorcycle. no. that's motorcycle insurance. slime everywhere? ughhh nooo, there's no insurance for that. do they help when i have bills health insurance doesn't cover? yeah! that's it! aflac! gross guys. get help with expenses health insurance doesn't cover. get to know us at aflac.com >> announcer: now the answer to today's aflac trivia question. what type of car saved french president charles de gaulle from an assassination attempt the answer -- citroen. >>> welcome back to "squawk box. the center for disease control reporting 153 cases of severe

joining us on the phone is former fda commissioner scott gottlieb thank you for joining us today we have settlement for johnson & johnson yesterday. now this talk of $10 billion to $12 billion for purdue being reported by nbc today. is this -- i guess is this the beginning of resolutions around the drugmakers around lawsuits for the drugmakers when you see the $10 billion to $12 billion does it set the bar higher in terms of what the settlements could look like? >> potentially if you look at where purdue is today relative to where it was. purdue was the company i think that in many respects is most culpable here and so i think the culpability should lie where the malfeasance was and purdue remember in 2007 the company that makes the narcotic painkiller oxycontin pled guilty to criminal charges at the time and paid $600 million penalty at that time and commiserate with that, three executives paid i think separately $35 million in fines so this company has already admitted to wrongdoing in the past and the latest settlement is part of an ongoing saga with pure due what we need to make sure

scott gottlieb left the fda earlier this year, returned to the american enterprise columnte, wrote aent in "the washington post" about cbd. phone lines for cbd users, 202-748-8003. otherwise, phone lines as usual. davia is up first out of huntsville. uses cbd. go ahead. caller: good morning, dr. gottlieb. i wanted to challenge you because it sounds like you are really only talking about cbd in the food supply. i'm actually recovering from my the head of the pain department at university of alabama birmingham highly recommends cbd as an alternative to opiates for pain treatment. , really, whatus are your thoughts on that? beinge talk about cbd hemp derived or cannabis derived, there are a lot of things and play with that as well as just molecular structure . guest: there's other active ingredients in the cannabis plant, certainly, and in cbd. cbd is available as a dietary supplement. dietary supplements are regulated under food regulations. when we talk about something being in the food supply, it is interchangeable with being a dietary supplement as well. the caller is referencing us

scott gottlieb, former head of the fda on why he thinks the fda needs to take more action on cbd. -- active a gradient ingredient in cannabis deriv

scott gottlieb who was the fda commissioner at the time to declare that youth vaping is an epidemic. we -- this concern was ree reinforced by the youth tobacco survey in 2018 when t. when the data was released to the public we could confirm past 30-day vaping increased from the prior year. and while an increase in use is of concern, our analysis showed that most adolescent vaping was occasional and that most regular use was concentrated in adolescents who had already been smokers and this -- i think this is an important point. yes, we need to be concerned about vaping, but we also need to be concerned about use of other tobacco products. and we also looked at youth who had never used tobacco products and thankfully vaping rates were quite low. again, this is not to minimize the importance of concern about youth vaping. cigarettes, smoking, remains a major concern here in the united states of america. and i'd also like to emphasize another point, which is that e-cigarettes have the potential to help adult smokers stop smoking. we've seen evidence accumulating that adult smokers who us

the former fda commissioner scott gottlieb is estimated that of all the bio similar to that event approved by fda actually made it to market in a timely fashion and the american consumers would save more than $4.5 billion. do you have any thoughts and do you support the provisions in our bill that attempts to prevent the gaming of the system to delay the advent of bio similar to the marketplace? >> absolutely. we strongly support any change that will enable increased access to bio similars and anything that prevents -- we believe there needs to be strong action on drug pricing and we strongly support the provision. >> thank you. >> thank you, senator collins. >> thank you, mr. chairman. ranking member murray thank you for your work to address rising healthcare costs. i also want to give your special thank you to your staff. these are complex issues and stakeholders and therefore income for your staff and they been terrific. americans have called on congress to act and i applaud members of this committee and both sides of the aisle for taking these calls seriously. i'm particularly encourag